HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

pimecrolimus (Elidel)

an ascomycin derivative; mechanism of action involves calcineurin inhibition, blockage of T cell activation, blocking signal transduction pathways in T cells, and inhibition of the synthesis of inflammatory cytokines, specifically Th1- and Th2-type cytokines
Also Known As:
Elidel; 33-epi-chloro-33-desoxyascomycin; ASM 981; SDZ ASM 981; SDZ-ASM-981
Networked: 600 relevant articles (165 outcomes, 178 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Bräutigam, Matthias: 15 articles (09/2013 - 01/2002)
2. Luger, Thomas: 12 articles (04/2022 - 01/2003)
3. Paul, Carle: 12 articles (01/2021 - 07/2002)
4. Eichenfield, Lawrence F: 12 articles (07/2016 - 04/2002)
5. Stuetz, Anton: 12 articles (09/2008 - 10/2002)
6. Boguniewicz, Mark: 10 articles (07/2016 - 04/2002)
7. Fölster-Holst, Regina: 10 articles (06/2015 - 01/2002)
8. Werfel, Thomas: 9 articles (01/2021 - 01/2004)
9. Meurer, Michael: 9 articles (06/2012 - 01/2002)
10. Luger, Thomas A: 8 articles (01/2013 - 06/2005)

Related Diseases

1. Atopic Dermatitis (Atopic Eczema)
2. Psoriasis (Pustulosis Palmaris et Plantaris)
3. Vitiligo
4. Pruritus (Itching)
5. Dermatitis

Related Drugs and Biologics

1. Tacrolimus (Prograf)
2. pimecrolimus (Elidel)
3. Adrenal Cortex Hormones (Corticosteroids)
4. Ointments (Pastes)
5. Calcineurin Inhibitors
6. Cytokines
7. Steroids
8. immunomycin (ascomycin)
9. Immunologic Factors (Immunomodulators)
10. Clobetasol (Clobetasol Propionate)

Related Therapies and Procedures

1. Therapeutics
2. Phototherapy (Light Therapy)
3. Percutaneous Collagen Induction
4. Off-Label Use
5. Cell- and Tissue-Based Therapy (Cell Therapy)